Everwell Health and its subsidiary, Nutrition21, have acquired all ingredient assets from Things of That Nature, Inc., which includes a novel plant-based cetylated fatty acid technology, esterified fatty acid compounds, and the Celadrin brand of ingredients for joint comfort, increased mobility, and skincare.

“This acquisition marks a significant milestone for our company since establishing the Everwell Health platform in 2021 with Nutrition21,” said Steve Rosenman, CEO of Everwell Health. “We’re committed to developing premium and effective ingredients that deliver exceptional value to both our customers and consumers. The science and technologies that we have acquired fit perfectly with our mission to deliver unique ingredients that empower all to look, feel, and perform their best. And by ‘all’, we mean both humans and companion animals. Our team is dedicated to developing and launching meaningful new wellness solutions for the supplement, food and beverage, and companion animal markets.”

There have been nearly a dozen studies on Celadrin, validating its respective roles in joint health, flexibility, and comfort by modulating the natural inflammatory response and promoting cell membrane function. The ingredient is also evidenced to benefit skin health with topical use.

Mobility and beauty benefits are emerging as top priorities for consumers. “In the last two years, we’ve observed strong growth in new products aimed at these health concerns. Joint health supplement launches have grown by nearly 11% CAGR from 2022-2024, while skin and beauty launches have risen by 13% CAGR,” said Jordan Miller, vice president of marketing for Nutrition21, citing Innova Market Insights.

Consumers are seeking healthy aging solutions earlier in life to maintain their physical abilities, prolong healthy function, and maintain a youthful appearance, Miller added. “Fifty-four percent of North American consumers express interest in products that address mobility even when they are not experiencing any symptoms, and 50% of consumers are interested in skincare products to visibly reduce the signs of aging,” he said, citing FMCG Gurus. “This demonstrates the immense potential for new and innovative approaches that support improved mobility, joint comfort, and skin health and appearance.”

Celadrin is currently sold and marketed in over a dozen countries, and is used in human, pet, and cosmetic applications. Existing customers can expect business as usual.

“We see great opportunity to expand the market presence of this established ingredient with our diverse customer base, and we intend to support customers with new scientific investment and deployment of substantial marketing capabilities,” said Rosenman.